Sanofi Genzyme Virtual Satellite Symposium

Sanofi Genzyme Satellite Symposium

How to Optimize the Treatment Sequence in Relapsed and Refractory Multiple Myeloma Patients – Evidence-Based Medicine

October 4, 2020
12:30 – 14:00

Chairs: Mohamad Mohty (France) and Hermann Einsele (Germany)
12:30 – 12:35 Welcome & Introduction
Mohamad Mohty (Paris, France) & Hermann Einsele (Würzburg, Germany)
12:35 – 12:50 First line treatment options and how they impact the following treatment decisions
Thierry Facon (Lille, France)
12:50 – 13:05 The role of Pomalidomide in the treatment of Lenalidomide-refractory multiple myeloma
Maria Victoria Mateos (Salamanca, Spain)
13:05 – 13:20 AntiCD38 antibody therapy in Lenalidomide-Refractory Multiple Myeloma patients: evidence-based therapy considerations
Philippe Moreau (Nantes, France)
13:20 – 13:35 Health-related quality of life in patients with relapsed/refractory multiple myeloma
Kwee Yong (London, UK)
13:35 – 14:00 Q&A and Panel discussion
Moderators: Mohamad Mohty & Hermann Einsele
Panel: Thierry Facon, Maria Victoria Mateos, Philippe Moreau, Kwee Yong